2-oxoimidazolidine-4-carboxamides as NAv1.8 inhibitors
US11802122B2 · kind B2 · utility
0Cited by
7References
46Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 15, 2021 |
| Grant date | Oct 31, 2023 |
| Priority date | — |
| Expiry date | Jun 15, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Novel compounds of the structural formula (I), and the pharmaceutically acceptable salts thereof, are inhibitors of Nav1.8 channel activity and may be useful in the treatment, prevention, management, amelioration, control and suppression of diseases mediated by Nav1.8 channel activity. The compounds of the present invention may be useful in the treatment, prevention or management of pain disorders, cough disorders, acute itch disorders, and chronic itch disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.